Application 219921

Type
NDA
Sponsor
AVYXA HOLDINGS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001KYXATACARBOPLATINSOLUTION;INTRAVENOUS20MG/2ML (10MG/ML)YesNo
002KYXATACARBOPLATINSOLUTION;INTRAVENOUS80MG/8ML (10MG/ML)YesYes
003KYXATACARBOPLATINSOLUTION;INTRAVENOUS500MG/50ML (10MG/ML)YesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83092ORIG 2025-08-12
83069ORIG 2025-08-11